Frontiers | DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications? | Pharmacology
Dipeptidyl peptidase-4 inhibitor - Wikipedia
The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin | Cardiovascular Diabetology | Full Text
Tolerability Profile of JANUVIA® (sitagliptin) When Added to Metformin vs Metformin Alone
![oral_hypoglycemic_drugs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c "oral_hypoglycemic_drugs [TUSOM | Pharmwiki]")
oral_hypoglycemic_drugs [TUSOM | Pharmwiki]
IJMS | Free Full-Text | Novel Potentials of the DPP-4 Inhibitor Sitagliptin against Ischemia-Reperfusion (I/R) Injury in Rat Ex-Vivo Heart Model | HTML
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
Continued) Oral diabetes medications: mechanism of action, side effects. | Download Scientific Diagram
![sitagliptin [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/dpp4.png?w=600&tok=f9724b "sitagliptin [TUSOM | Pharmwiki]")
sitagliptin [TUSOM | Pharmwiki]
Randomized trial assessing the safety and efficacy of sitagliptin in Chinese patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea alone or combined with metformin - Ba - 2017 - Journal
The incretin hormone GLP‐1 and mechanisms underlying its secretion - Tian - 2016 - Journal of Diabetes - Wiley Online Library
Presentation sitagliptin
Sitagliptin vs. pioglitazone as add-on treatments in patients with uncontrolled type 2 diabetes on the maximal dose of metformin plus sulfonylurea | SpringerLink
Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study | BMC Endocrine Disorders
Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram
Sitagliptin Phosphate Monohydrate
Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome: Trends in Endocrinology & Metabolism
Mechanism of Action | JANUVIA® (sitagliptin)
Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma‐associated antigen‐A3 expression through Yes‐associated protein inactivation - Wang - 2020 - Cancer Medicine - Wiley Online Library
Dipeptidyl peptidase-4 inhibitor Glucagon-like peptide-1 receptor agonist Liraglutide Dulaglutide, others, angle, text, pharmaceutical Drug png | PNGWing
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence | Nature Reviews Nephrology
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
Cardiovascular effects of sitagliptin – An anti‐diabetes medicine - Zhou - 2018 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library
Oral Antidiabetic Agents - ppt download
DPP-4 Inhibitor | Januvia | Diabetes Medicine
